Phase 3 Hypoglycaemia Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
The C*STEROID Trial: Corticosteroids before planned caesarean section from 35+0 to 39+6 weeks of pregnancy.
Transient tachypnoea of the newbornNeonatal hypoglycaemiaCaesarean section delivery+1 more
The University of Auckland2,548 enrolled23 locationsACTRN12620000914965
Completed
Phase 2Phase 3
Diazoxide for babies with severe or recurrent low blood glucose: The Neonatal Glucose Care Optimisation (NeoGluCO) Study
Neonatal hypoglycaemia
Liggins Institute, University of Auckland74 enrolled1 locationACTRN12620000129987
Terminated
Phase 3
The C*STEROID Feasibility Study: a two-site, randomised placebo controlled trial of corticosteroids before planned caesarean section delivery at 35+0 to 39+6 weeks of pregnancy to determine feasibility for recruitment to the C*STEROID Trial.
Transient tachypnoea of the newbornNeonatal hypoglycaemiaCaesarean section delivery+1 more
University of Auckland400 enrolled1 locationACTRN12618002028280
Completed
Phase 2Phase 3
In clinic evaluation of an "artificial pancreas" for the management of type 1 diabetes, when possible hypoglycaemia causing scenarios are simulated.
Hypoglycaemia
Dr Martin de Bock8 enrolled1 locationACTRN12614001005640
Completed
Phase 3Phase 4
Vildagliptin in type 1 diabetes mellitus added to insulin
HypoglycaemiaGlycamic variability
BakerIDI Heart and Diabetes Institute72 enrolled1 locationACTRN12613001056785